Bile duct cancer cells and normal cells 3D photolithography image difference Bile duct cancer, a malignant tumor that occurs in the bile duct, is difficult to diagnose early because there are few ...

在肝内胆管癌（ICC）治疗领域，化疗免疫治疗（CIT）取得了显著进展，但仍面临着治疗抵抗的挑战。铁死亡是一种细胞死亡形式，与癌症的发生、发展及治疗抵抗密切相关。PCK1作为代谢关键酶，在多种癌症中发挥着重要作用，但其在ICC中的具体作用尚不清楚。

It's a deadly cancer with a complicated name and for too long there've been limited treatment options for sufferers, until ...

The magnetic resonance (MR) imaging appearance of cholangiocarcinoma depends on the amount of fibrosis, necrosis, and mucinous material within the tumor. Most frequently it appears as a ...

SAN DIEGO — A one-unit increase in cholangioscopy procedures was linked to a 24% increase in subsequent cholangiocarcinoma diagnoses the following year, according to research presented at ...

Tinengotinib in patients with advanced, metastatic cholangiocarcinoma: Overall survival results and biomarker correlative analysis from a phase 2 clinical trial.

In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...

Cholangiocarcinoma, known more commonly as bile duct (or biliary) cancer, has several features that historically have made it difficult to treat. First, it is a rare cancer, so advances in treatment ...

Futibatinib, an inhibitor of fibroblast growth factor receptors 1–4, has shown promising antitumor activity in patients with intrahepatic cholangiocarcinoma with FGFR2 fusions or rearrangements ...

Global licensing agreement grants Elevar Therapeutics worldwide rights to develop and commercialize lirafugratinib (RLY-4008)Lirafugratinib is a potential best-in-class FGFR2 inhibitor that has ...

Cholangiocarcinoma is a rare cancer that develops from the bile ducts, which are slender tubes that carry the digestive fluid bile and connect the liver to the gallbladder and small intestine.

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that it has completed ...